Login / Signup

Prenatal molecular diagnosis in RASA1-related disease.

Asurélien PalmyreMélanie EyriesMarie-Victoire SenatAugustin OzanneStéphanie StaraciPhilippe DufourThierry ChinetPascal LacombeFlorent SoubrierPhilippe Charron
Published in: Prenatal diagnosis (2017)
RASA1-related disease is a rare autosomal dominant disease characterized by capillary malformations, arteriovenous malformations (AVMs), and/or arteriovenous fistulas (AFVs). Penetrance is nearly complete and vascular malformations may cause serious complications such as organ injury due to oxygenation disorder, brain abscess, hemorrhage, and stroke. Early diagnosis is useful in order to discuss optimal management, including AVMs/AVFs embolization or surgical procedures, and try to prevent some of the complications. In this context, molecular testing of RASA1 gene mutation in relatives may help to better manage the family. All arteriovenous malformations are however not accessible to such procedures. In addition, these therapeutic procedures may result in potential side effects and complications. A couple was referred to our genetics unit and asked us for prenatal genetic testing about a RASA1 mutation. Here, we discuss about arguments that led our team to accept prenatal testing. To the best of our knowledge, no molecular prenatal diagnosis was reported until now in RASA1-related diseases. This first report of prenatal diagnosis in RASA1-related diseases may also offer perspectives for a more general discussion in the field of inherited arteriovenous malformations.
Keyphrases
  • pregnant women
  • healthcare
  • risk factors
  • single molecule
  • brain injury
  • subarachnoid hemorrhage
  • blood flow